U.S. markets close in 3 hours 14 minutes

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
121.90-7.87 (-6.06%)
As of 12:46PM EST. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
719
719
289,590
3,124
40,997
Operating Expense
355,154
355,154
242,850
162,067
105,645
Operating Income
-354,435
-354,435
46,740
-158,943
-64,648
Net Non Operating Interest Income Expense
-
-
-
0
-
Other Income Expense
6,379
6,379
20,566
-5,485
-1,960
Pretax Income
-348,056
-348,056
67,306
-164,428
-66,608
Tax Provision
809
809
448
553
1,749
Net Income Common Stockholders
-348,865
-348,865
66,858
-164,981
-68,357
Diluted NI Available to Com Stockholders
-348,865
-348,865
66,858
-164,981
-68,357
Basic EPS
-
-
0.0012
-0.0034
-0.0017
Diluted EPS
-
-
0.0012
-0.0034
-0.0017
Basic Average Shares
-
-
54,392
47,964
40,057
Diluted Average Shares
-
-
56,933
47,964
40,057
Total Operating Income as Reported
-354,435
-354,435
46,740
-158,943
-64,648
Total Expenses
355,154
355,154
242,850
162,067
105,645
Net Income from Continuing & Discontinued Operation
-348,865
-348,865
66,858
-164,981
-68,357
Normalized Income
-348,865
-348,865
66,858
-164,981
-68,357
Interest Expense
-
-
-
0
-
Net Interest Income
-
-
-
0
-
EBIT
-354,435
-354,435
46,740
-164,428
-64,648
EBITDA
-345,251
-
-
-
-
Reconciled Depreciation
9,184
9,184
4,725
3,519
3,024
Net Income from Continuing Operation Net Minority Interest
-348,865
-348,865
66,858
-164,981
-68,357
Total Unusual Items Excluding Goodwill
-
-
-
0
-
Total Unusual Items
-
-
-
0
-
Normalized EBITDA
-345,251
-345,251
51,465
-160,909
-61,624
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0